Axial’s assessment relies on a weighted methodology that tracks deal progression from the initial market introduction through to signed letters of intent and final closures. VERTESS outperformed its peers by maintaining high levels of buyer engagement and consistent success in navigating complex healthcare transactions. Managing Partner Vaughne Glennie attributed the firm's success to a persistent focus on integrity and personalized guidance for business owners navigating the high-stakes environment of a company sale.
In section Releases
VERTESS Secures Top Spot in 2026 Healthcare M&A Advisor Rankings
Fort Worth-based advisory firm VERTESS has clinched the number one position on Axial's 2026 list of top sell-side healthcare M&A advisors. The ranking, which evaluates transaction volume and deal effectiveness, highlights the firm’s influence in the lower middle market as activity in sectors like behavioral health continues to accelerate.
Beyond individual rankings, the report sheds light on broader market shifts. Data from the 2026 Healthcare M&A Outlook Survey identifies Behavioral and Mental Health as the most active sector, cited by 69% of respondents. While Healthcare IT continues to command premium valuation multiples, Physician Practices are seeing high volume but more modest valuations. For those planning an exit in the coming years, VERTESS Managing Director Connor Cruse emphasizes that early preparation is critical to maximizing enterprise value and attracting qualified buyers.
Comments (0)
No comments yet. Be the first!